ATP2C2

ATPase secretory pathway Ca2+ transporting 2, the group of ATPases Ca2+ transporting

Basic information

Region (hg38): 16:84368527-84464187

Links

ENSG00000064270NCBI:9914OMIM:613082HGNC:29103Uniprot:O75185AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ATP2C2 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ATP2C2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
26
clinvar
11
clinvar
37
missense
125
clinvar
13
clinvar
13
clinvar
151
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
1
clinvar
1
clinvar
2
splice region
1
8
3
12
non coding
6
clinvar
4
clinvar
10
Total 0 0 126 46 28

Variants in ATP2C2

This is a list of pathogenic ClinVar variants found in the ATP2C2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
16-84368623-A-G not specified Uncertain significance (Jun 07, 2023)2558426
16-84368651-A-T not specified Uncertain significance (Jun 05, 2024)3329134
16-84368656-G-A not specified Uncertain significance (Feb 06, 2023)2481365
16-84368670-G-A not specified Uncertain significance (Oct 02, 2023)3131619
16-84368680-A-G ATP2C2-related disorder Likely benign (Dec 27, 2022)3047719
16-84368710-C-G not specified Uncertain significance (Aug 17, 2021)2385306
16-84398553-C-T ATP2C2-related disorder Likely benign (Jun 06, 2019)3044808
16-84398569-C-T not specified Uncertain significance (Jun 02, 2023)2555804
16-84398570-G-C ATP2C2-related disorder Likely benign (Oct 30, 2018)790327
16-84405153-A-T not specified Conflicting classifications of pathogenicity (Jan 18, 2024)2048303
16-84405187-C-G ATP2C2-related disorder Likely benign (Aug 29, 2019)3053590
16-84405214-C-T ATP2C2-related disorder Likely benign (Mar 20, 2019)3057295
16-84405215-G-A not specified Uncertain significance (Jan 03, 2022)2386944
16-84405221-G-A Conflicting classifications of pathogenicity (Mar 01, 2023)547871
16-84408400-T-G Likely benign (Jun 06, 2018)738488
16-84408455-C-A Likely benign (Mar 01, 2023)2646918
16-84408489-G-A Benign (Dec 31, 2019)779452
16-84410590-T-C not specified Uncertain significance (Jul 08, 2022)2405353
16-84410598-A-T not specified Uncertain significance (Mar 24, 2023)2529727
16-84410600-C-G ATP2C2-related disorder Benign (Apr 25, 2019)3052394
16-84410600-C-T Likely benign (Aug 16, 2018)764990
16-84410733-G-C not specified Uncertain significance (Nov 21, 2023)3131616
16-84410753-C-T not specified Uncertain significance (Jan 30, 2024)3131617
16-84415491-A-G not specified Uncertain significance (Sep 12, 2023)2622708
16-84415502-C-G not specified Uncertain significance (Mar 14, 2023)3131618

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ATP2C2protein_codingprotein_codingENST00000262429 2795661
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
5.02e-605.09e-141222782225411248410.0103
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-5.599505731.660.00003576136
Missense in Polyphen469276.561.69582851
Synonymous-8.504232511.680.00001831887
Loss of Function-3.447549.01.530.00000243578

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.009810.00978
Ashkenazi Jewish0.001090.00109
East Asian0.002370.00234
Finnish0.02650.0263
European (Non-Finnish)0.01170.0116
Middle Eastern0.002370.00234
South Asian0.009490.00936
Other0.01140.0114

dbNSFP

Source: dbNSFP

Function
FUNCTION: This magnesium-dependent enzyme catalyzes the hydrolysis of ATP coupled with the transport of calcium. {ECO:0000250}.;
Pathway
Vitamin D Receptor Pathway;Ion channel transport;Transport of small molecules;Ion transport by P-type ATPases (Consensus)

Recessive Scores

pRec
0.105

Intolerance Scores

loftool
0.113
rvis_EVS
-0.35
rvis_percentile_EVS
29.6

Haploinsufficiency Scores

pHI
0.145
hipred
hipred_score
ghis
0.473

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.189

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumHigh
CancerHighMediumHigh

Mouse Genome Informatics

Gene name
Atp2c2
Phenotype

Gene ontology

Biological process
cellular calcium ion homeostasis;calcium ion transmembrane transport;manganese ion transmembrane transport;ATP hydrolysis coupled cation transmembrane transport;proton transmembrane transport
Cellular component
Golgi membrane;integral component of membrane
Molecular function
calcium-transporting ATPase activity;protein binding;ATP binding;proton-exporting ATPase activity, phosphorylative mechanism;manganese-transporting ATPase activity;metal ion binding